Liquidia Corporation (LQDA)
NASDAQ: LQDA · Real-Time Price · USD
78.93
-0.39 (-0.49%)
At close: Jul 2, 2026, 4:00 PM EDT
78.94
+0.01 (0.01%)
After-hours: Jul 2, 2026, 7:31 PM EDT
Liquidia Market Cap
Liquidia has a market cap or net worth of $7.02 billion as of July 2, 2026. Its market cap has increased by 504.19% in one year.
Market Cap
7.02B
Enterprise Value
6.98B
1-Year Change
504.19%
Ranking
Category
Stock Price
$78.93
Market Cap Chart
Since July 26, 2018, Liquidia's market cap has increased from $167.77M to $7.02B, an increase of 4,083.65%. That is a compound annual growth rate of 60.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 7.02B | 133.93% |
| Dec 31, 2025 | 3.00B | 201.46% |
| Dec 31, 2024 | 995.33M | 20.97% |
| Dec 29, 2023 | 822.82M | 100.28% |
| Dec 30, 2022 | 410.83M | 62.30% |
| Dec 31, 2021 | 253.13M | 98.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neurocrine Biosciences | 17.04B |
| Elanco Animal Health | 12.20B |
| Dr. Reddy's Laboratories | 11.73B |
| Alkermes | 8.73B |
| Hims & Hers Health | 8.70B |
| Lantheus Holdings | 7.14B |
| Amneal Pharmaceuticals | 5.49B |
| Indivior Pharmaceuticals | 4.87B |